BPA for ampyra, qutenza

Ended Awarded Last action

Contract number
36E79718A0009
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$50,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00011 · 2023 public law pricing updates $0
Exercise an Option P00010 · Exercise the fourth option year on BPA 36E79718A0009 $0
Supplemental Agreement for work within scope P00009 · 2022 public law pricing updates $0
Exercise an Option P00008 · Exercise option year 3. $0
Supplemental Agreement for work within scope P00007 · 2021 public law pricing updates $0
Exercise an Option P00006 · Extend the performance period of BPA to 02/14/2021 $0
Supplemental Agreement for work within scope P00005 · 2020 public law pricing updates $0
Supplemental Agreement for work within scope P00004 · Product addition of inbrija inhaler product. $0
Exercise an Option P00003 · Exercise option year 1 $0
Supplemental Agreement for work within scope P00001 · Qutenza product deletion $0
Supplemental Agreement for work within scope P00002 · 2019 public law updates $0
Original award $0
Show all 12

Quick answers

Who was awarded contract 36E79718A0009?

36E79718A0009 was awarded to Acorda Therapeutics, Inc. by National Acquisition Center (Headquarters) on February 15, 2018.

How much is contract 36E79718A0009 worth?

36E79718A0009's own ceiling is $50,000,000.

Who can order from contract 36E79718A0009?

36E79718A0009 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79718A0009 under another contract?

Yes. 36E79718A0009 is a blanket purchase agreement under 36F79718D0361, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79718A0009 competed?

The extent of competition for 36E79718A0009 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV